Vaccination strategies in lymphoproliferative disorders: Failures and successes

•Anti-tumor vaccines hold out the prospect of effective tumor therapies.•Lymphomas are weakly immunogenic.•This prevent the recognition of tumor-associated antigens by cytotoxic T lymphocytes.•We focus on the results of clinical trials of vaccination in lymphoma.•We discuss potential strategies to enhance the efficacy of immunotherapy.